Senores Pharmaceuticals Limited (SENORES) reported revenue of ₹180 Cr and net profit of ₹30.45 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
SENORES fundamentals, Fundamental score 84/100
The statements below are read from Senores Pharmaceuticals Limited’s filed results, 11 filed quarters and 5 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Jul 27, 2026 · audited
Sales CAGR · 3Y+162.4%FY22 → FY25
Sales CAGR · 4Y+159.3%FY21 → FY25
PAT CAGR · 3Y+147.7%FY22 → FY25
PAT CAGR · 4Y+232.0%FY21 → FY25
Price · 1Y+102.9%EOD
Price CAGR · 3Y—EOD
Consolidated view — the full group. Senores Pharmaceuticals Limited's standalone figures are parent-only (₹27 cr), a fraction of the group.
Quarterly resultsConsolidated
₹ Cr
Dec2023
Mar2024
Jun2024
Sep2024
Dec2024
Mar2025
Jun2025
Sep2025
Dec2025
Mar2026
Jun2026Latest
YoYlatest
Sales
79.0
102
80.0
101
103
114
138
162
175
175
180
+30.6%
64.0
80.0
59.0
77.0
77.3
94.8
104
112
121
128
126
+21.8%
Operating profit
15.0
22.0
21.0
24.0
25.7
19.4
34.2
49.5
54.0
47.5
53.8
+57.3%
OPM %
19.0%
21.6%
26.3%
23.8%
24.9%
17.0%
24.8%
30.6%
30.9%
27.1%
29.8%
+5.1 pp
Other income
1.00
2.00
0.00
2.00
5.16
11.8
3.36
5.41
3.78
17.7
2.81
-16.4%
Interest
2.00
3.00
5.00
5.00
6.16
5.30
5.04
6.19
5.33
8.46
7.17
+42.3%
Depreciation
3.00
4.00
4.00
4.00
4.20
5.23
6.00
8.09
7.85
9.30
9.94
+65.7%
Profit before tax
10.0
18.0
13.0
16.0
20.5
20.7
26.5
40.6
44.6
47.4
39.5
+49.0%
Tax %
30.0%
22.2%
15.4%
18.8%
19.8%
13.1%
20.0%
25.9%
24.7%
22.6%
22.8%
+2.8 pp
Net profit
7.00
14.0
11.0
13.0
16.4
18.0
21.2
30.1
33.6
36.7
30.5
+43.8%
EPS (₹)
2.37
5.23
3.23
3.86
5.04
3.81
4.60
6.54
7.29
7.96
6.61
+43.7%
One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split↔ scroll for earlier quarters
Revenue & net profit trend
last 11 quarters
RevenueNet profit
Revenue & net profit — Consolidated11 quarters
Segment results
Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.
Forensic checksauto-scanned from the filing
Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.
How results moved the priceEOD reaction on the session the market could trade the filing
Avg absolute result-day move ±7.0%· EPS surprise: no estimates source· 3 earlier quarters have no dated filing on record
